Mustang Bio Inc reports results for the quarter ended in December - Earnings Summary

Mustang Bio

23/03/2022 20:48

* Mustang Bio Inc  MBIO.OQ  reported a quarterly adjusted
loss
of 22 cents​​ per share for the quarter ended in December. The
mean expectation of five analysts for the quarter was for a loss
of 19 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Mustang Bio Inc's reported EPS for the quarter was a loss
of 22
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Mustang Bio Inc shares had fallen by 38.0% this quarter.
    * The company reported a quarterly loss of $20.05 million.
    * Wall Street's median 12-month price target for Mustang Bio
Inc
is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 23 at 08:48 p.m.  ​All
figures in US dollars unless otherwise stated